[go: up one dir, main page]

BR9912218A - Compostos obtidos de espécies de sálvia possuindo atividade antivirótica - Google Patents

Compostos obtidos de espécies de sálvia possuindo atividade antivirótica

Info

Publication number
BR9912218A
BR9912218A BR9912218-9A BR9912218A BR9912218A BR 9912218 A BR9912218 A BR 9912218A BR 9912218 A BR9912218 A BR 9912218A BR 9912218 A BR9912218 A BR 9912218A
Authority
BR
Brazil
Prior art keywords
compounds obtained
tetramers
trimers
compositions
dimers
Prior art date
Application number
BR9912218-9A
Other languages
English (en)
Inventor
Myun K Han
Paul Lee
Original Assignee
Univ Georgetown
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Georgetown filed Critical Univ Georgetown
Publication of BR9912218A publication Critical patent/BR9912218A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
    • C08F246/00—Copolymers in which the nature of only the monomers in minority is defined
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/59—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyureas or polyurethanes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

"COMPOSTOS OBTIDOS DE ESPéCIES DE SáLVIA POSSUINDO ATIVIDADE ANTIVIRóTICA". São providas composições compreendendo moléculas possuindo, pelo menos, uma porção de ácido <225>-(3,4-dihidroxifenil)láctico e/ou ácido caféico que são encontradas em extratos de plantas do gênero Salvia, as porções sendo da fórmula (I), os agentes ativos possuindo um peso molecular de pelo menos 190 Dáltons. Uma classe de agentes preferidos é constituída daqueles que são conjugados para formar dímeros, trímeros, tetrâmeros e polímeros maiores contendo as porções, com os mais preferidos sendo dímeros de ácido salvianólico, trímeros, tetrâmeros e polímeros maiores. Os compostos e as composições podem ser administrados como veículos e excipientes farmaceuticamente aceitáveis sistemática ou localmente, para tratar infecções víróticas.
BR9912218-9A 1998-06-25 1999-06-25 Compostos obtidos de espécies de sálvia possuindo atividade antivirótica BR9912218A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/104,363 US6037369A (en) 1998-06-25 1998-06-25 Compounds obtained from salvia species having antiviral Activity
PCT/US1999/014297 WO1999066942A1 (en) 1998-06-25 1999-06-25 Compounds obtained from salvia species having antiviral activity

Publications (1)

Publication Number Publication Date
BR9912218A true BR9912218A (pt) 2002-07-23

Family

ID=22300096

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9912218-9A BR9912218A (pt) 1998-06-25 1999-06-25 Compostos obtidos de espécies de sálvia possuindo atividade antivirótica

Country Status (18)

Country Link
US (1) US6037369A (pt)
EP (1) EP1089747A1 (pt)
JP (1) JP2002518455A (pt)
KR (1) KR20010071580A (pt)
CN (1) CN1312722A (pt)
AU (1) AU740698B2 (pt)
BR (1) BR9912218A (pt)
CA (1) CA2335956A1 (pt)
CZ (1) CZ20004858A3 (pt)
HU (1) HUP0103398A2 (pt)
ID (1) ID28792A (pt)
IL (1) IL140483A0 (pt)
IS (1) IS5792A (pt)
MX (1) MXPA01000195A (pt)
NO (1) NO20006631L (pt)
PL (1) PL345086A1 (pt)
TR (1) TR200100450T2 (pt)
WO (1) WO1999066942A1 (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20000069296A (ko) * 1996-12-05 2000-11-25 윌리암 제이.하트만 항바이러스 활성을 갖는 살비아 종의 추출물
US6043276A (en) * 1998-06-25 2000-03-28 Georgetown University School Of Medicine Compounds obtained from salvia species having antiviral activity
ATE304859T1 (de) * 2000-05-05 2005-10-15 Parsenn Produkte Ag Verwendung einer zubereitung zur topischen behandlung von durch virusinfektionen verursachten manifestationen
SG98409A1 (en) * 2000-06-21 2003-09-19 Chi Chiang Yang Pharmaceutical compositions and combinations for the treatment or prophylaxis of disorders related to hiv and retrovirus
JP2002020283A (ja) * 2000-06-22 2002-01-23 Yang Chi-Chiang Ｈｉｖおよびレトロウイルスに関連する障害の処置または予防のための薬学的組成物および組み合わせ
KR20020005222A (ko) * 2000-06-28 2002-01-17 치-치앙 양 Ｈｉｖ 또는 레트로바이러스에 관련된 질환의 치료 또는예방용 약학적 조성물 및 조합물
AU2001293048A1 (en) * 2000-09-26 2002-04-08 The Johns Hopkins University Antiviral compositions and methods of use
US20070027209A1 (en) * 2005-08-01 2007-02-01 Lee Hyun C Prevention and treatment of atherosclerosis with lithospermate B
WO2008117901A1 (en) * 2007-03-28 2008-10-02 Industry-Academic Cooperation Foundation, Yonsei University A method for isolation of high concentration of magnesium lithospermate b from salviae miltiorrhizae
WO2010111935A1 (zh) * 2009-03-30 2010-10-07 天津天士力制药股份有限公司 一种新的丹酚酸化合物l、其制备方法和用途
CN101919836A (zh) * 2009-06-17 2010-12-22 山东绿叶天然药物研究开发有限公司 迷迭香酸的新用途
CN103054976B (zh) * 2011-10-21 2014-09-24 上海中医药大学 一种治疗血小板减少症的中药组合物及其制备方法和应用
CN103845403B (zh) * 2014-02-27 2016-10-05 河南大学 丹参配方颗粒在制备预防和治疗艾滋病脑病药物方面的应用
CN104974119B (zh) * 2014-04-01 2018-10-19 中国科学院上海药物研究所 一种高纯度丹酚酸b镁及其制备方法
CN108042524A (zh) * 2017-12-21 2018-05-18 南方医科大学 丹酚酸b及其结构类似物在制备抗hpv病毒感染药物中的应用
CN109771410B (zh) * 2019-03-06 2020-11-24 湖北大学 紫草酸在制备抗乙肝病毒药物中的用途
CN109771407B (zh) * 2019-03-29 2021-11-26 成都医学院 迷迭香酸在制备抑制水痘-带状疱疹病毒的药物中的用途
CN110922286B (zh) * 2019-11-23 2022-08-16 上海化工研究院有限公司 一种非对称芳基取代富烯化合物及其制备方法与应用
JP7778685B2 (ja) * 2020-04-30 2025-12-02 富士フイルム富山化学株式会社 ピラジン誘導体と他のコロナウイルス感染症治療薬とを組み合わせてなるコロナウイルス感染症治療剤
CN114712342B (zh) * 2022-05-10 2023-04-21 湖北大学 紫草酸在制备抗流感病毒药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178865A (en) * 1990-06-19 1993-01-12 Cedars-Sinai Medical Center Chinese herbal extracts in the treatment of hiv related disease in vitro
US5346695A (en) * 1991-03-27 1994-09-13 Tampa Bay Research Institute Methods of inhibiting HIV replication in vitro using polymers of p-hydroxylated cinnamic acids
KR20000069296A (ko) * 1996-12-05 2000-11-25 윌리암 제이.하트만 항바이러스 활성을 갖는 살비아 종의 추출물

Also Published As

Publication number Publication date
CZ20004858A3 (cs) 2001-09-12
AU740698B2 (en) 2001-11-15
CA2335956A1 (en) 1999-12-29
IS5792A (is) 2000-12-22
IL140483A0 (en) 2002-02-10
AU4714999A (en) 2000-01-10
WO1999066942A1 (en) 1999-12-29
MXPA01000195A (es) 2002-04-24
WO1999066942A9 (en) 2000-06-22
NO20006631D0 (no) 2000-12-22
KR20010071580A (ko) 2001-07-28
PL345086A1 (en) 2001-12-03
ID28792A (id) 2001-07-05
NO20006631L (no) 2001-02-26
EP1089747A1 (en) 2001-04-11
HUP0103398A2 (hu) 2002-01-28
TR200100450T2 (tr) 2001-07-23
CN1312722A (zh) 2001-09-12
US6037369A (en) 2000-03-14
JP2002518455A (ja) 2002-06-25

Similar Documents

Publication Publication Date Title
BR9912218A (pt) Compostos obtidos de espécies de sálvia possuindo atividade antivirótica
BR0115109A (pt) Agentes terapêuticos e métodos de uso dos mesmos para a modulação da angiogênese
BR0008840A (pt) Derivados de camptotecina tendo atividade antitumoral
BR0110420A (pt) Agonistas muscarìnicos
BR0009200A (pt) Compostos e composições para o tratamento dedoenças associada com disfunção imune
BR0108401A (pt) Análogos de nucleosìdeos com base bicìclica modificada por carboxamidina
BR0312286A (pt) pró-medicamentos de 2&#39; e 3&#39; - nucleosìdeo modificado para tratamento de infecções por flaviviridae
BR9206631A (pt) Sistema de maior penetração na pele para melhor administração tópica de medicamentos
WO1998004290A3 (en) Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
BR0000003A (pt) Azalidas e métodos de preparação das mesmas
BR0012136A (pt) Inibidores de reabsorção de norepinefrina altamente seletivos e métodos de uso dos mesmos
EA200100870A1 (ru) Композиции-ингибиторы циклооксигеназы-2 с быстро наступающим терапевтическим действием
BRPI0112962B8 (pt) composições farmacêuticas compreendendo ácido hialurônico, ácido glicirretínico e polivinilpirrolidona, e uso desses compostos na preparação de medicamentos
BR9810745A (pt) Derivados de benzimidazol
AR008378A1 (es) Conjudados de interferon
BR0314236A (pt) Formulação de oligonucleotìdeo, composição farmacêutica, kit, composto antiviral, preparação de oligonucleotìdeo e métodos para seleção de um oligonucleotìdeo antiviral para uso como um agente antiviral, para profilaxia ou tratamento de uma infecção viral em um paciente, para tratamento profilático de câncer causado por oncovìrus, para identificação de um composto que altera a ligação de um oligonucleotìdeo a pelo menos um componente viral, para purificação da ligação de oligonucleotìdeos a pelo menos um componente viral e para enriquecimento de oligonucleotìdeos a partir de um agrupamento de oligonucleotìdeos
BR9912694A (pt) Composto para preparar medicamento de administração pulmonar
BR0109779A (pt) Soluções moleculares hidrofìlicas dispersas de carvedilol
DE69731610D1 (de) Orale verabreichung wirksamer mengen von hyaluronsäure
BR9916422A (pt) Saponinas antiprotozoárias
BRPI0412502A (pt) derivados de ariltiouréia substituìda úteis como inibidores de replicação viral
BR9813319A (pt) Composto, composição farmacêutica para tratamento de infecções bacterianas, e, processos para tratar infecções bacterianas e para preparar um composto
ES2060173T3 (es) Derivados de lisolecitina para el tratamiento de enfermedades autoinmunologicas.
BR0008829A (pt) Inibição sinérgica de replicação viral porhidrocarbonetos de cadeia longa e análogos denucleosìdeos
BR9803233A (pt) Preparação de combinação farmacêutica de um inibidor do trocador de sódio/hidrogênio e um medicamento para o tratamento de doenças cardiovasculares.

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]
B15K Others concerning applications: alteration of classification

Ipc: C08F 246/00 (2006.01), A61K 31/19 (2006.0